Gulf International Bank (UK)’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $6.17M | Buy |
7,986
+2,637
| +49% | +$2.02M | 0.14% | 137 |
|
|
2025
Q4 | $4.13M | Buy |
5,349
+11
| +0.2% | +$7.47K | 0.13% | 132 |
|
|
2025
Q3 | $3M | Sell |
5,338
-109
| -2% | -$61.6K | 0.1% | 195 |
|
|
2025
Q2 | $2.86M | Sell |
5,447
-880
| -14% | -$491K | 0.1% | 190 |
|
|
2025
Q1 | $4.01M | Sell |
6,327
-2,097
| -25% | -$1.44M | 0.14% | 152 |
|
|
2024
Q4 | $6M | Sell |
8,424
-92
| -1% | -$77.2K | 0.15% | 125 |
|
|
2024
Q3 | $8.95M | Sell |
8,516
-346
| -4% | -$385K | 0.23% | 81 |
|
|
2024
Q2 | $9.31M | Sell |
8,862
-45
| -0.5% | -$43.6K | 0.23% | 87 |
|
|
2024
Q1 | $8.57M | Buy |
8,907
+43
| +0.5% | +$40.9K | 0.22% | 95 |
|
|
2023
Q4 | $7.79M | Sell |
8,864
-978
| -10% | -$805K | 0.22% | 99 |
|
|
2023
Q3 | $8.1M | Sell |
9,842
-1,000
| -9% | -$786K | 0.23% | 91 |
|
|
2023
Q2 | $7.79M | Sell |
10,842
-2,824
| -21% | -$2.18M | 0.19% | 100 |
|
|
2023
Q1 | $11.2M | Sell |
13,666
-4,300
| -24% | -$3.24M | 0.23% | 92 |
|
|
2022
Q4 | $13M | Hold |
17,966
| – | – | 0.23% | 95 |
|
|
2022
Q3 | $12.4M | Buy |
17,966
+1,300
| +8% | +$818K | 0.23% | 86 |
|
|
2022
Q2 | $9.96M | Sell |
16,666
-55
| -0.3% | -$35.8K | 0.18% | 117 |
|
|
2022
Q1 | $11.7M | Buy |
16,721
+125
| +0.8% | +$79.1K | 0.17% | 116 |
|
|
2021
Q4 | $10.5M | Sell |
16,596
-3,280
| -17% | -$2.02M | 0.15% | 138 |
|
|
2021
Q3 | $12M | Sell |
19,876
-219
| -1% | -$136K | 0.15% | 133 |
|
|
2021
Q2 | $11.2M | Sell |
20,095
-49
| -0.2% | -$24.8K | 0.14% | 146 |
|
|
2021
Q1 | $9.53M | Sell |
20,144
-2,705
| -12% | -$1.32M | 0.13% | 155 |
|
|
2020
Q4 | $11M | Sell |
22,849
-1,540
| -6% | -$831K | 0.14% | 139 |
|
|
2020
Q3 | $13.7M | Sell |
24,389
-613
| -2% | -$372K | 0.19% | 108 |
|
|
2020
Q2 | $15.6M | Buy |
25,002
+4,895
| +24% | +$2.78M | 0.24% | 86 |
|
|
2020
Q1 | $9.82M | Buy |
20,107
+1,767
| +10% | +$729K | 0.19% | 116 |
|
|
2019
Q4 | $6.89M | Sell |
18,340
-164
| -0.9% | -$55.2K | 0.1% | 194 |
|
|
2019
Q3 | $5.13M | Sell |
18,504
-49
| -0.3% | -$14.5K | 0.09% | 246 |
|
|
2019
Q2 | $5.81M | Hold |
18,553
| – | – | 0.1% | 221 |
|
|
2019
Q1 | $7.62M | Buy |
18,553
+70
| +0.4% | +$28.8K | 0.13% | 171 |
|
|
2018
Q4 | $6.9M | Sell |
18,483
-8,582
| -32% | -$3.14M | 0.14% | 163 |
|
|
2018
Q3 | $10.9M | Buy |
27,065
+1,977
| +8% | +$752K | 0.13% | 173 |
|
|
2018
Q2 | $8.65M | Buy |
25,088
+600
| +2% | +$188K | 0.11% | 203 |
|
|
2018
Q1 | $8.43M | Sell |
24,488
-297
| -1% | -$103K | 0.11% | 206 |
|
|
2017
Q4 | $9.32M | Hold |
24,785
| – | – | 0.12% | 195 |
|
|
2017
Q3 | $11.1M | Buy |
24,785
+300
| +1% | +$143K | 0.15% | 159 |
|
|
2017
Q2 | $12M | Buy |
24,485
+430
| +2% | +$188K | 0.17% | 134 |
|
|
2017
Q1 | $9.32M | Buy |
24,055
+825
| +4% | +$306K | 0.14% | 172 |
|
|
2016
Q4 | $8.53M | Buy |
23,230
+35
| +0.2% | +$13.3K | 0.13% | 179 |
|
|
2016
Q3 | $9.32M | Hold |
23,195
| – | – | 0.15% | 154 |
|
|
2016
Q2 | $8.1M | Buy |
23,195
+239
| +1% | +$92K | 0.14% | 170 |
|
|
2016
Q1 | $8.27M | Hold |
22,956
| – | – | 0.14% | 161 |
|
|
2015
Q4 | $12.5M | Buy |
22,956
+400
| +2% | +$217K | 0.22% | 104 |
|
|
2015
Q3 | $10.5M | Buy |
22,556
+50
| +0.2% | +$26.9K | 0.2% | 118 |
|
|
2015
Q2 | $11.5M | Sell |
22,506
-40
| -0.2% | -$19.5K | 0.2% | 120 |
|
|
2015
Q1 | $10.2M | Buy |
22,546
+75
| +0.3% | +$31.8K | 0.18% | 131 |
|
|
2014
Q4 | $9.22M | Buy |
22,471
+300
| +1% | +$118K | 0.16% | 149 |
|
|
2014
Q3 | $7.99M | Hold |
22,171
| – | – | 0.15% | 160 |
|
|
2014
Q2 | $6.26M | Hold |
22,171
| – | – | 0.12% | 208 |
|
|
2014
Q1 | $6.66M | Buy |
22,171
+428
| +2% | +$132K | 0.13% | 188 |
|
|
2013
Q4 | $5.99M | Buy |
+21,743
| New | +$6.25M | 0.12% | 200 |
|
Other funds holding REGN
VCM
N
Gulf International Bank (UK)'s REGN Position: Q1 2026 in Review
Gulf International Bank (UK) increased its Regeneron Pharmaceuticals (REGN) stake by 49% in Q1 2026, buying an estimated $2.02M and bringing the position to 7,986 shares worth $6.17M. The position accounts for 0.14% of the portfolio, ranked #137.
Gulf International Bank (UK) first reported a position in REGN in Q4 2013 and has held it in 50 quarters since. The position peaked at $15.6M in Q2 2020. 1,396 funds tracked by Wall St. Rank hold REGN as of Q1 2026.
- Gulf International Bank (UK) held 7,986 shares of Regeneron Pharmaceuticals worth $6.17M as of Q1 2026.
- Gulf International Bank (UK) bought 2,637 Regeneron Pharmaceuticals shares in Q1 2026, an estimated $2.02M.
- Regeneron Pharmaceuticals made up 0.14% of Gulf International Bank (UK)'s portfolio in Q1 2026, its #137 holding.
- Gulf International Bank (UK) first reported a position in Regeneron Pharmaceuticals in Q4 2013 and has held it in 50 quarters since.
- Gulf International Bank (UK)'s Regeneron Pharmaceuticals position peaked at $15.6M in Q2 2020.
- 1,396 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2026.
Based on Gulf International Bank (UK)'s 13F filing for Q1 2026, filed 11 May 2026.